United States · FDA National Drug Code directory

SODIUM PHENYLACETATE AND SODIUM BENZOATE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68382-396_6ad04728-e1b6-4851-9614-1322607ce238
Product NDC: 68382-396
Form: INJECTION, SOLUTION, CONCENTRATE
Composition / generic term: sodium phenylacetate and sodium benzoate
Labeler: Zydus Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20210208
Source listing expiry: 20261231

Source-listed ingredients

SODIUM PHENYLACETATE — 100 mg/mL
SODIUM BENZOATE — 100 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

1 VIAL in 1 CARTON (68382-396-01) / 50 mL in 1 VIAL · 68382-396-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →